Skip to Main Content

Paper Details

Serrate RNA Effector Molecule (SRRT) Is Associated with Prostate Cancer Progression and Is a Predictor of Poor Prognosis in Lethal Prostate Cancer.
Cancers (Basel)
0
2023
ARS2, ATM, Arsenite, Arsenite-resistance protein 2, ERG, Lethal Prostate Cancer, PCa, PRAD, PSA, PTEN, Prostate Cancer, RNA, RNAseq, SRRT, SRRT mRNA, Serrate RNA Effector Molecule, androgen, genes, mutant TP53, patients, prostate cancer, serrate RNA effector molecule, therapeutic
Author NameAffiliation
Yaser GamallatUniversity of Calgary Cumming School of Medicine
Yaser GamallatUniversity of Calgary Cumming School of Medicine
Yaser GamallatArnie Charbonneau Cancer Institute and Tom Baker Cancer Center
Muhammad ChoudhryUniversity of Calgary Cumming School of Medicine
Qiaowang LiUniversity of Calgary
Jon RokneUniversity of Calgary
Reda AlhajjUniversity of Calgary
Reda AlhajjIstanbul Medipol University
Reda AlhajjUniversity of Southern Denmark
Randa A Abdel SalamUniversity of Calgary Cumming School of Medicine
Sunita GhoshUniversity of Alberta
Jaron Arbetand Jonsson Comprehensive Cancer Center, University of California los angeles
Paul C Boutrosand Jonsson Comprehensive Cancer Center, University of California los angeles
Tarek A BismarUniversity of Calgary Cumming School of Medicine
Tarek A BismarUniversity of Calgary Cumming School of Medicine
Tarek A BismarArnie Charbonneau Cancer Institute and Tom Baker Cancer Center
Tarek A BismarProstate Cancer Centre
  • 1 - 17

Datasets

Release 1.2